Veradermics (MANE) Non-Current Assets (2025 - 2026)
Veradermics' Non-Current Assets was $989,000 in Q2 2026, up 244.6% from the prior quarter.
Powered by 
Analysis
Veradermics (MANE) Non-Current Assets (2025 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Veradermics came in at $125,000.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.13 Bn | 1,102.72 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.88 Bn | 261.87 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.36 Bn | 235.05 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 235.80 Bn | 191.20 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 190.78 Bn | 164.97 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 169.43 Bn | 116.08 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Veradermics | 5.55 Bn | 4.14 Bn | - | 989,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 989,000.00 |
| Mar 31, 2026 | 287,000.00 |
| Dec 31, 2025 | 125,000.00 |
API Access
Veradermics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=MANE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "MANE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=MANE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();